{"transactions":[{"id":2345228,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Common Stock","published_at":"2022-03-08T23:45:52.000Z","date":"2022-03-07","kind":"tax_withholding","acquired":false,"shares":5399,"price":36.83,"value":198845.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on 03/07/2022 and does not represent a sale by the reporting person."}],"balance_after":153233,"source":{"system":"sec-edgar","filing":"0001061983-22-000067","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000067/edgardoc.xml","form_type":"4"}},{"id":2356260,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-03-03T21:40:06.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":46138,"price":37.63,"value":1736172.94,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant."}],"balance_after":46138,"derivative":{"exercise_price":37.63,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":46138},"source":{"system":"sec-edgar","filing":"0001061983-22-000053","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000053/edgardoc.xml","form_type":"4"}},{"id":2356259,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2022-03-03T21:40:06.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":3862,"price":37.63,"value":145327.06,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant."}],"balance_after":3862,"derivative":{"exercise_price":37.63,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":3862},"source":{"system":"sec-edgar","filing":"0001061983-22-000053","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000053/edgardoc.xml","form_type":"4"}},{"id":2356258,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Common Stock","published_at":"2022-03-03T21:40:06.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Comprised of restricted stock units that will vest over 3 years, with 40% vesting on the 1-year anniversary of the grant, an additional 40% vesting on the 2-year anniversary of the grant, and the final 20% vesting on the 3-year anniversary of the grant."}],"balance_after":158632,"source":{"system":"sec-edgar","filing":"0001061983-22-000053","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000053/edgardoc.xml","form_type":"4"}},{"id":2356257,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Common Stock","published_at":"2022-03-03T21:40:06.000Z","date":"2022-03-02","kind":"tax_withholding","acquired":false,"shares":3458,"price":37.63,"value":130124.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on 03/02/2022 and does not represent a sale by the reporting person."}],"balance_after":138632,"source":{"system":"sec-edgar","filing":"0001061983-22-000053","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000053/edgardoc.xml","form_type":"4"}},{"id":2366400,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Common Stock","published_at":"2022-03-02T00:40:16.000Z","date":"2022-02-28","kind":"tax_withholding","acquired":false,"shares":2071,"price":35.32,"value":73147.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on 02/28/2022 and does not represent a sale by the reporting person."}],"balance_after":142090,"source":{"system":"sec-edgar","filing":"0001061983-22-000037","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000037/edgardoc.xml","form_type":"4"}},{"id":2389362,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Common Stock","published_at":"2022-02-18T00:47:16.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Comprised of restricted stock units (RSUs) issued upon conversion of certain PSUs granted to the Reporting Person on May 11, 2021. The satisfaction and certification of the performance metric resulted in a portion of the PSUs being converted into RSUs of the Issuer. These RSUs will vest in whole on February 16, 2023."}],"balance_after":144161,"source":{"system":"sec-edgar","filing":"0001061983-22-000025","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000025/edgardoc.xml","form_type":"4"}},{"id":2389361,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Common Stock","published_at":"2022-02-18T00:47:16.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":1883,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On or about May 11, 2021, the Reporting Person was granted performance-based stock units (PSUs) of the Issuer, which upon satisfaction and certification of the performance metric resulted in a portion of the PSUs being converted into fully-vested shares of common stock of the Issuer."}],"balance_after":141036,"source":{"system":"sec-edgar","filing":"0001061983-22-000025","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000025/edgardoc.xml","form_type":"4"}},{"id":2520165,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-11-09T22:35:14.000Z","date":"2021-11-09","kind":"exercise","acquired":false,"shares":24519,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":9.65,"exercise_date":"2014-03-24","expiration_date":"2024-02-24","underlying":"Common Stock","underlying_shares":24519},"source":{"system":"sec-edgar","filing":"0001061983-21-000255","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000255/edgardoc.xml","form_type":"4"}},{"id":2520164,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2021-11-09T22:35:14.000Z","date":"2021-11-09","kind":"exercise","acquired":false,"shares":20481,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":9.65,"exercise_date":"2014-03-24","expiration_date":"2024-02-24","underlying":"Common Stock","underlying_shares":20481},"source":{"system":"sec-edgar","filing":"0001061983-21-000255","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000255/edgardoc.xml","form_type":"4"}},{"id":2520163,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Common Stock","published_at":"2021-11-09T22:35:14.000Z","date":"2021-11-09","kind":"sale","acquired":false,"shares":20481,"price":41.7602,"value":855290.6562,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":138704,"source":{"system":"sec-edgar","filing":"0001061983-21-000255","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000255/edgardoc.xml","form_type":"4"}},{"id":2520162,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Common Stock","published_at":"2021-11-09T22:35:14.000Z","date":"2021-11-09","kind":"exercise","acquired":true,"shares":20481,"price":9.65,"value":197641.65,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":159185,"source":{"system":"sec-edgar","filing":"0001061983-21-000255","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000255/edgardoc.xml","form_type":"4"}},{"id":2520161,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Common Stock","published_at":"2021-11-09T22:35:14.000Z","date":"2021-11-09","kind":"sale","acquired":false,"shares":24519,"price":41.7602,"value":1023918.3438,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":138704,"source":{"system":"sec-edgar","filing":"0001061983-21-000255","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000255/edgardoc.xml","form_type":"4"}},{"id":2520160,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Common Stock","published_at":"2021-11-09T22:35:14.000Z","date":"2021-11-09","kind":"exercise","acquired":true,"shares":24519,"price":9.65,"value":236608.35,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":163223,"source":{"system":"sec-edgar","filing":"0001061983-21-000255","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000255/edgardoc.xml","form_type":"4"}},{"id":2529504,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-11-02T21:16:43.000Z","date":"2021-11-01","kind":"exercise","acquired":false,"shares":6675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2021."}],"balance_after":0,"derivative":{"exercise_price":6,"exercise_date":"2013-04-05","expiration_date":"2023-03-05","underlying":"Common Stock","underlying_shares":6675},"source":{"system":"sec-edgar","filing":"0001061983-21-000247","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000247/edgardoc.xml","form_type":"4"}},{"id":2529503,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2021-11-02T21:16:43.000Z","date":"2021-11-01","kind":"exercise","acquired":false,"shares":18325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2021."}],"balance_after":0,"derivative":{"exercise_price":6,"exercise_date":"2013-04-05","expiration_date":"2023-03-05","underlying":"Common Stock","underlying_shares":18325},"source":{"system":"sec-edgar","filing":"0001061983-21-000247","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000247/edgardoc.xml","form_type":"4"}},{"id":2529502,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Common Stock","published_at":"2021-11-02T21:16:43.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":18325,"price":34.8896,"value":639351.92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Amount of securities beneficially owned following reported transaction has been adjusted by 1,541 shares purchased pursuant to ESPP but were not previously reported. Reporting persons Form 4 filed on 10/1/2021 erroneously stated that the reported 137,123 shares owned following reporting persons transaction on October 1, 2021 included 13,678 shares of common stock purchased pursuant to ESPP, but in fact only 12,137 shares of common stock purchased pursuant to ESPP were included in that 137,123 share total."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":138704,"source":{"system":"sec-edgar","filing":"0001061983-21-000247","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000247/edgardoc.xml","form_type":"4"}},{"id":2529501,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Common Stock","published_at":"2021-11-02T21:16:43.000Z","date":"2021-11-01","kind":"exercise","acquired":true,"shares":18325,"price":6,"value":109950.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Amount of securities beneficially owned following reported transaction has been adjusted by 1,541 shares purchased pursuant to ESPP but were not previously reported. Reporting persons Form 4 filed on 10/1/2021 erroneously stated that the reported 137,123 shares owned following reporting persons transaction on October 1, 2021 included 13,678 shares of common stock purchased pursuant to ESPP, but in fact only 12,137 shares of common stock purchased pursuant to ESPP were included in that 137,123 share total."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":157029,"source":{"system":"sec-edgar","filing":"0001061983-21-000247","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000247/edgardoc.xml","form_type":"4"}},{"id":2529500,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Common Stock","published_at":"2021-11-02T21:16:43.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":6675,"price":34.8896,"value":232888.08,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Amount of securities beneficially owned following reported transaction has been adjusted by 1,541 shares purchased pursuant to ESPP but were not previously reported. Reporting persons Form 4 filed on 10/1/2021 erroneously stated that the reported 137,123 shares owned following reporting persons transaction on October 1, 2021 included 13,678 shares of common stock purchased pursuant to ESPP, but in fact only 12,137 shares of common stock purchased pursuant to ESPP were included in that 137,123 share total."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":138704,"source":{"system":"sec-edgar","filing":"0001061983-21-000247","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000247/edgardoc.xml","form_type":"4"}},{"id":2529499,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Common Stock","published_at":"2021-11-02T21:16:43.000Z","date":"2021-11-01","kind":"exercise","acquired":true,"shares":6675,"price":6,"value":40050.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Amount of securities beneficially owned following reported transaction has been adjusted by 1,541 shares purchased pursuant to ESPP but were not previously reported. Reporting persons Form 4 filed on 10/1/2021 erroneously stated that the reported 137,123 shares owned following reporting persons transaction on October 1, 2021 included 13,678 shares of common stock purchased pursuant to ESPP, but in fact only 12,137 shares of common stock purchased pursuant to ESPP were included in that 137,123 share total."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":145379,"source":{"system":"sec-edgar","filing":"0001061983-21-000247","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000247/edgardoc.xml","form_type":"4"}},{"id":2554882,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Common Stock","published_at":"2021-10-01T20:34:11.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":7569,"price":35.142,"value":265989.798,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":137123,"source":{"system":"sec-edgar","filing":"0001061983-21-000219","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000219/edgardoc.xml","form_type":"4"}},{"id":2582302,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Common Stock","published_at":"2021-09-02T20:08:39.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":7850,"price":32.7785,"value":257311.225,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":144692,"source":{"system":"sec-edgar","filing":"0001061983-21-000208","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000208/edgardoc.xml","form_type":"4"}},{"id":2620405,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Common Stock","published_at":"2021-08-02T22:59:42.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":2616,"price":29.67,"value":77616.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":152542,"source":{"system":"sec-edgar","filing":"0001061983-21-000200","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000200/edgardoc.xml","form_type":"4"}},{"id":2645662,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Common Stock","published_at":"2021-07-02T20:22:48.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":6013,"price":19.8701,"value":119478.9113,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":155158,"source":{"system":"sec-edgar","filing":"0001061983-21-000162","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000162/edgardoc.xml","form_type":"4"}},{"id":2687316,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-06-02T20:45:38.000Z","date":"2021-06-01","kind":"exercise","acquired":false,"shares":6562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2021."}],"balance_after":0,"derivative":{"exercise_price":6.3,"exercise_date":"2012-04-05","expiration_date":"2022-03-05","underlying":"Common Stock","underlying_shares":6562},"source":{"system":"sec-edgar","filing":"0001061983-21-000154","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000154/edgardoc.xml","form_type":"4"}},{"id":2687315,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2021-06-02T20:45:38.000Z","date":"2021-06-01","kind":"exercise","acquired":false,"shares":8437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2021."}],"balance_after":0,"derivative":{"exercise_price":6.3,"exercise_date":"2012-04-05","expiration_date":"2022-03-05","underlying":"Common Stock","underlying_shares":8437},"source":{"system":"sec-edgar","filing":"0001061983-21-000154","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000154/edgardoc.xml","form_type":"4"}},{"id":2687314,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Common Stock","published_at":"2021-06-02T20:45:38.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":8437,"price":21.6274,"value":182470.3738,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":161171,"source":{"system":"sec-edgar","filing":"0001061983-21-000154","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000154/edgardoc.xml","form_type":"4"}},{"id":2687313,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Common Stock","published_at":"2021-06-02T20:45:38.000Z","date":"2021-06-01","kind":"exercise","acquired":true,"shares":8437,"price":6.3,"value":53153.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":169608,"source":{"system":"sec-edgar","filing":"0001061983-21-000154","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000154/edgardoc.xml","form_type":"4"}},{"id":2687312,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Common Stock","published_at":"2021-06-02T20:45:38.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":6562,"price":21.6274,"value":141918.9988,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":161171,"source":{"system":"sec-edgar","filing":"0001061983-21-000154","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000154/edgardoc.xml","form_type":"4"}},{"id":2687311,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief HR & Admin Officer"}}],"security":"Common Stock","published_at":"2021-06-02T20:45:38.000Z","date":"2021-06-01","kind":"exercise","acquired":true,"shares":6562,"price":6.3,"value":41340.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":167733,"source":{"system":"sec-edgar","filing":"0001061983-21-000154","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000154/edgardoc.xml","form_type":"4"}},{"id":2800914,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Common Stock","published_at":"2021-03-09T23:55:15.000Z","date":"2021-03-08","kind":"tax_withholding","acquired":false,"shares":4150,"price":19.19,"value":79638.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on 03/06/2021 and does not represent a sale by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes up to 13,132 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":160625,"source":{"system":"sec-edgar","filing":"0001061983-21-000075","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000075/edgardoc.xml","form_type":"4"}},{"id":2809489,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-03-04T21:56:38.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":34879,"price":19.42,"value":677350.18,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant."}],"balance_after":34879,"derivative":{"exercise_price":19.42,"exercise_date":"2021-04-02","expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":34879},"source":{"system":"sec-edgar","filing":"0001061983-21-000058","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000058/edgardoc.xml","form_type":"4"}},{"id":2809488,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2021-03-04T21:56:38.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":10121,"price":19.42,"value":196549.82,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant."}],"balance_after":10121,"derivative":{"exercise_price":19.42,"exercise_date":"2021-04-02","expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":10121},"source":{"system":"sec-edgar","filing":"0001061983-21-000058","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000058/edgardoc.xml","form_type":"4"}},{"id":2809487,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Common Stock","published_at":"2021-03-04T21:56:38.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Comprised of restricted stock  units that will vest over 3 years, with 40% vesting on the 1-year anniversary of the grant, an additional 40% vesting on the 2-year anniversary of the grant, and the final 20% vesting on the 3-year anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes up to 13,132 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":164775,"source":{"system":"sec-edgar","filing":"0001061983-21-000058","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000058/edgardoc.xml","form_type":"4"}},{"id":2821828,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Common Stock","published_at":"2021-03-03T00:32:07.000Z","date":"2021-03-01","kind":"tax_withholding","acquired":false,"shares":2075,"price":19.66,"value":40794.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on 03/01/2021 and does not represent a sale by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes up to 13,132 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":139775,"source":{"system":"sec-edgar","filing":"0001061983-21-000048","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000048/edgardoc.xml","form_type":"4"}},{"id":2827393,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Common Stock","published_at":"2021-03-01T21:59:39.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":4379,"price":18.73,"value":82018.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on 02/26/2021 and does not represent a sale by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes up to 13,132 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":141850,"source":{"system":"sec-edgar","filing":"0001061983-21-000040","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000040/edgardoc.xml","form_type":"4"}},{"id":2940655,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-12-17T23:05:19.000Z","date":"2020-12-15","kind":"exercise","acquired":false,"shares":9243,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":9.42,"exercise_date":"2011-03-31","expiration_date":"2021-02-28","underlying":"Common Stock","underlying_shares":9243},"source":{"system":"sec-edgar","filing":"0001061983-20-000189","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000189/edgardoc.xml","form_type":"4"}},{"id":2940654,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-12-17T23:05:19.000Z","date":"2020-12-15","kind":"exercise","acquired":false,"shares":7423,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9243,"derivative":{"exercise_price":9.42,"exercise_date":"2011-03-31","expiration_date":"2021-02-28","underlying":"Common Stock","underlying_shares":7423},"source":{"system":"sec-edgar","filing":"0001061983-20-000189","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000189/edgardoc.xml","form_type":"4"}},{"id":2940653,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-12-17T23:05:19.000Z","date":"2020-12-15","kind":"exercise","acquired":true,"shares":7423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Incentive stock options granted on 2/28/2011 to purchase 7,423 shares at an exercise price of $9.42 per share converted to non-qualified stock options to purchase 7,423 shares at an exercise price of $9.42 per share as a result of a modification to the original grant to permit a \"net exercise\" of the stock options.  Conversion transaction is permitted pursuant to the Issuer's Amended and Restated 2004 Equity Incentive Plan and the prior resolution of the Issuer's Compensation and Talent Committee of the Board of Directors."}],"balance_after":16666,"derivative":{"exercise_price":9.42,"exercise_date":"2011-03-31","expiration_date":"2021-02-28","underlying":"Common Stock","underlying_shares":7423},"source":{"system":"sec-edgar","filing":"0001061983-20-000189","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000189/edgardoc.xml","form_type":"4"}},{"id":2940652,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2020-12-17T23:05:19.000Z","date":"2020-12-15","kind":"exercise","acquired":false,"shares":7423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Incentive stock options granted on 2/28/2011 to purchase 7,423 shares at an exercise price of $9.42 per share converted to non-qualified stock options to purchase 7,423 shares at an exercise price of $9.42 per share as a result of a modification to the original grant to permit a \"net exercise\" of the stock options.  Conversion transaction is permitted pursuant to the Issuer's Amended and Restated 2004 Equity Incentive Plan and the prior resolution of the Issuer's Compensation and Talent Committee of the Board of Directors."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Number of derivative securities beneficially owned following reported transaction is zero (0). The 1 security that is reported is the result of rounding of shares attributable to Issuer?s reverse stock split that occurred on 6/25/2013."}],"balance_after":1,"derivative":{"exercise_price":9.42,"exercise_date":"2011-03-31","expiration_date":"2021-02-28","underlying":"Common Stock","underlying_shares":7423},"source":{"system":"sec-edgar","filing":"0001061983-20-000189","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000189/edgardoc.xml","form_type":"4"}},{"id":2940651,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Common Stock","published_at":"2020-12-17T23:05:19.000Z","date":"2020-12-15","kind":"tax_withholding","acquired":false,"shares":5908,"price":21,"value":124068.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction represents a \"net exercise\" of 9,243 outstanding non-qualified stock options granted on 2/28/2011 and 7,423 outstanding non-qualified stock options that result from the conversion on 12/15/20 of incentive stock options granted on 2/28/2011. The Reporting Person received 6,013 shares of Common Stock on the net exercise of a stock options to purchase an aggregate of 16,666 shares of Common Stock, with a remaining payable by Reporting Person to the Issuer of $17.45. The Issuer withheld 10,653 shares of Common Stock underlying the stock options for payment of the exercise price and tax withholding using a stock price on 12/15/20 of $21.00. In addition to the withholding of 10,653 shares of Common Stock, the Reporting Person will pay $17.45 in cash to the Issuer for the remainder of his exercise price and tax liability."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes up to 13,132 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":146229,"source":{"system":"sec-edgar","filing":"0001061983-20-000189","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000189/edgardoc.xml","form_type":"4"}},{"id":2940650,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Common Stock","published_at":"2020-12-17T23:05:19.000Z","date":"2020-12-15","kind":"exercise","acquired":true,"shares":9243,"price":9.42,"value":87069.06,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes up to 13,132 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":152137,"source":{"system":"sec-edgar","filing":"0001061983-20-000189","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000189/edgardoc.xml","form_type":"4"}},{"id":2940649,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Common Stock","published_at":"2020-12-17T23:05:19.000Z","date":"2020-12-15","kind":"tax_withholding","acquired":false,"shares":4745,"price":21,"value":99645.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction represents a \"net exercise\" of 9,243 outstanding non-qualified stock options granted on 2/28/2011 and 7,423 outstanding non-qualified stock options that result from the conversion on 12/15/20 of incentive stock options granted on 2/28/2011. The Reporting Person received 6,013 shares of Common Stock on the net exercise of a stock options to purchase an aggregate of 16,666 shares of Common Stock, with a remaining payable by Reporting Person to the Issuer of $17.45. The Issuer withheld 10,653 shares of Common Stock underlying the stock options for payment of the exercise price and tax withholding using a stock price on 12/15/20 of $21.00. In addition to the withholding of 10,653 shares of Common Stock, the Reporting Person will pay $17.45 in cash to the Issuer for the remainder of his exercise price and tax liability."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes up to 13,132 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":142894,"source":{"system":"sec-edgar","filing":"0001061983-20-000189","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000189/edgardoc.xml","form_type":"4"}},{"id":2940648,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Common Stock","published_at":"2020-12-17T23:05:19.000Z","date":"2020-12-15","kind":"exercise","acquired":true,"shares":7423,"price":9.42,"value":69924.66,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes up to 13,132 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":147639,"source":{"system":"sec-edgar","filing":"0001061983-20-000189","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000189/edgardoc.xml","form_type":"4"}},{"id":3221113,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-03-09T20:33:12.000Z","date":"2020-03-06","kind":"grant","acquired":true,"shares":50408,"price":14.4,"value":725875.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant."}],"balance_after":50408,"derivative":{"exercise_price":14.4,"expiration_date":"2030-03-05","underlying":"Common Stock","underlying_shares":50408},"source":{"system":"sec-edgar","filing":"0001061983-20-000062","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000062/edgardoc.xml","form_type":"4"}},{"id":3221112,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2020-03-09T20:33:12.000Z","date":"2020-03-06","kind":"grant","acquired":true,"shares":9592,"price":14.4,"value":138124.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant."}],"balance_after":9592,"derivative":{"exercise_price":14.4,"expiration_date":"2030-03-05","underlying":"Common Stock","underlying_shares":9592},"source":{"system":"sec-edgar","filing":"0001061983-20-000062","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000062/edgardoc.xml","form_type":"4"}},{"id":3221111,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Common Stock","published_at":"2020-03-09T20:33:12.000Z","date":"2020-03-06","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes up to 11,616 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":139098,"source":{"system":"sec-edgar","filing":"0001061983-20-000062","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000062/edgardoc.xml","form_type":"4"}},{"id":3234030,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Common Stock","published_at":"2020-03-03T18:44:49.000Z","date":"2020-02-28","kind":"tax_withholding","acquired":false,"shares":1384,"price":13.94,"value":19292.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on 02/28/2020 and does not represent a sale by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes up to 11,616 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":109098,"source":{"system":"sec-edgar","filing":"0001061983-20-000051","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000051/edgardoc.xml","form_type":"4"}},{"id":3238884,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Common Stock","published_at":"2020-03-02T23:18:48.000Z","date":"2020-02-27","kind":"tax_withholding","acquired":false,"shares":4150,"price":13.94,"value":57851.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on 02/27/2020 and does not represent a sale by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes up to 11,616 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":110482,"source":{"system":"sec-edgar","filing":"0001061983-20-000044","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000044/edgardoc.xml","form_type":"4"}},{"id":3241873,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Common Stock","published_at":"2020-02-28T20:38:32.000Z","date":"2020-02-26","kind":"tax_withholding","acquired":false,"shares":4431,"price":14.065,"value":62322.015,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on 02/26/2020 and does not represent a sale by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes up to 11,616 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan."}],"balance_after":114632,"source":{"system":"sec-edgar","filing":"0001061983-20-000036","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000036/edgardoc.xml","form_type":"4"}},{"id":3620069,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-03-04T21:04:34.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":33889,"price":7.14,"value":241967.46,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant."}],"balance_after":33889,"derivative":{"exercise_price":7.14,"expiration_date":"2029-02-26","underlying":"Common Stock","underlying_shares":33889},"source":{"system":"sec-edgar","filing":"0001061983-19-000022","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198319000022/edgardoc.xml","form_type":"4"}},{"id":3620068,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2019-03-04T21:04:34.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":16111,"price":7.14,"value":115032.54,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant."}],"balance_after":16111,"derivative":{"exercise_price":7.14,"expiration_date":"2029-02-26","underlying":"Common Stock","underlying_shares":16111},"source":{"system":"sec-edgar","filing":"0001061983-19-000022","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198319000022/edgardoc.xml","form_type":"4"}},{"id":3620067,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Common Stock","published_at":"2019-03-04T21:04:34.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"This award shall vest over three years in annual installments: 40% one year from the date of grant, 40% two years from the date of grant and 20% three years from the date of grant."}],"balance_after":116783,"source":{"system":"sec-edgar","filing":"0001061983-19-000022","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198319000022/edgardoc.xml","form_type":"4"}},{"id":4024804,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-03-02T00:11:38.000Z","date":"2018-02-27","kind":"grant","acquired":true,"shares":24268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"When the ISO and NQ dated 02/27/2018 are combined, the total grant shall vest and become exercisable in equal monthly installments such that the option shall be 100% vested on 02/27/2022."}],"balance_after":24268,"derivative":{"exercise_price":7.8,"expiration_date":"2028-02-27","underlying":"Common Stock","underlying_shares":24268},"source":{"system":"sec-edgar","filing":"0001061983-18-000014","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000014/edgardoc.xml","form_type":"4"}},{"id":4024803,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2018-03-02T00:11:38.000Z","date":"2018-02-27","kind":"grant","acquired":true,"shares":15732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"When the ISO and NQ dated 02/27/2018 are combined, the total grant shall vest and become exercisable in equal monthly installments such that the option shall be 100% vested on 02/27/2022."}],"balance_after":15732,"derivative":{"exercise_price":7.8,"expiration_date":"2028-02-27","underlying":"Common Stock","underlying_shares":15732},"source":{"system":"sec-edgar","filing":"0001061983-18-000014","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000014/edgardoc.xml","form_type":"4"}},{"id":4024802,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Common Stock","published_at":"2018-03-02T00:11:38.000Z","date":"2018-02-28","kind":"tax_withholding","acquired":false,"shares":2730,"price":7.75,"value":21157.5,"ownership":{"direct":true},"balance_after":85865,"source":{"system":"sec-edgar","filing":"0001061983-18-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000014/edgardoc.xml","form_type":"4"}},{"id":4024801,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Common Stock","published_at":"2018-03-02T00:11:38.000Z","date":"2018-02-28","kind":"tax_withholding","acquired":false,"shares":5741,"price":7.75,"value":44492.75,"ownership":{"direct":true},"balance_after":88595,"source":{"system":"sec-edgar","filing":"0001061983-18-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000014/edgardoc.xml","form_type":"4"}},{"id":4024800,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Common Stock","published_at":"2018-03-02T00:11:38.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":15000,"price":0.001,"value":15.0,"ownership":{"direct":true},"balance_after":94336,"source":{"system":"sec-edgar","filing":"0001061983-18-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000014/edgardoc.xml","form_type":"4"}},{"id":4024799,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Common Stock","published_at":"2018-03-02T00:11:38.000Z","date":"2018-02-27","kind":"grant","acquired":true,"shares":30000,"price":0.001,"value":30.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The restricted stock units vest in three annual installments.  Vested shares will be delivered to the reporting person as follows: 40% on 02/27/2019, 40% on 02/27/2020 and 20% on 03/01/2021."}],"balance_after":79336,"source":{"system":"sec-edgar","filing":"0001061983-18-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000014/edgardoc.xml","form_type":"4"}},{"id":4410658,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-03-03T00:05:09.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":14166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"When the ISO and NQ dated 02/28/2017 are combined, the total grant shall vest and become exercisable in equal monthly installments such that the option shall be 100% vested on 02/28/2021."}],"balance_after":14166,"derivative":{"exercise_price":10.6,"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":14166},"source":{"system":"sec-edgar","filing":"0001061983-17-000014","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000014/edgardoc.xml","form_type":"4"}},{"id":4410657,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-03-03T00:05:09.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":5834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"When the ISO and NQ dated 02/28/2017 are combined, the total grant shall vest and become exercisable in equal monthly installments such that the option shall be 100% vested on 02/28/2021."}],"balance_after":5834,"derivative":{"exercise_price":10.6,"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":5834},"source":{"system":"sec-edgar","filing":"0001061983-17-000014","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000014/edgardoc.xml","form_type":"4"}},{"id":4410656,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Common Stock","published_at":"2017-03-03T00:05:09.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":20000,"price":0.001,"value":20.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The restricted stock units vest in three annual installments.  Vested shares will be delivered to the reporting person as follows: 40% on 02/28/2018, 40% on 02/28/2019 and 20% on 02/28/2020."}],"balance_after":48018,"source":{"system":"sec-edgar","filing":"0001061983-17-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000014/edgardoc.xml","form_type":"4"}},{"id":4410655,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Common Stock","published_at":"2017-03-03T00:05:09.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":6008,"price":10.6,"value":63684.8,"ownership":{"direct":true},"balance_after":28018,"source":{"system":"sec-edgar","filing":"0001061983-17-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000014/edgardoc.xml","form_type":"4"}},{"id":4410654,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129399,"kind":"person","name":"Cragg David","position":1,"cik":"0001316459","reported_name":"Cragg David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Human Resources"}}],"security":"Common Stock","published_at":"2017-03-03T00:05:09.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":15000,"price":0.001,"value":15.0,"ownership":{"direct":true},"balance_after":34026,"source":{"system":"sec-edgar","filing":"0001061983-17-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000014/edgardoc.xml","form_type":"4"}}]}